Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Guangdong Fapon Biotech Co., Ltd.

Download Mobile App




Blood Tests for Diabetes Reassessed for Reliability

By LabMedica International staff writers
Posted on 19 May 2011
The routine oral glucose tolerance test and the glycosylated hemoglobin (HbA1c) blood tests have been compared for their use in prediabetes diagnosis. More...


The expert recommendation to use HbA1c test in place of fasting blood glucose levels to screen for and diagnose diabetes is not universally accepted and needs to be tested in clinical settings.

Scientists at the Mayo Clinic (Scottsdale, AZ, USA) examined the blood of 242 patients who were entering a diabetes prevention program between January 1, 2007, and September 13, 2009. They analyzed the participant's baseline oral glucose tolerance test and HbA1c results. Glucose determinations and HbA1c levels were performed on a chemistry analyzer. Blood glucose values are determined by the standard hexokinase assay. The HbA1c determination was based on turbidimetric immunoinhibition using hemolyzed whole blood.

Patients were classified as having impaired fasting glucose (IFG), or impaired glucose tolerance (IGT), or combined IFG and IGT based on oral glucose tolerance test results. The scientists calculated the percentage of patients with IFG and IGT who had HbA1c values in the ranges of 5.7% to 6.4% and 6.0% to 6.4%. The mean age with standard deviation (SD) of the patients was 62 ± 11 years; 64.0% were women, and 88.0% were white. The mean with SD for fasting glucose level was 110 ± 8 mg/dL, the two-hour glucose level was 137 ± 35 mg/dL and HbA1c level was 5.8% ± 0.36%. Isolated IFG was detected in about 56.2% of patients and combined IFG and IGT in about 37.2%. Only 28.5% of patients had HbA1c values in the 6.0% to 6.4% range, whereas 65.3% had values in the 5.7% to 6.4% range. The chemistry analyzer used was the Roche Cobas 6000 (Roche Professional Diagnostics; Indianapolis, IN, USA).

The authors concluded that for their purposes, a diabetes prevention program, by relying solely on the HbA1c testing, a substantial number of eligible patients would be overlooked. They deemed it reasonable to continue using fasting glucose levels, at least for their diabetes prevention program, as the initial screening method for determining eligibility for participation. The study was published in May 2011, in the American Journal of Clinical Pathology.

Related Links:

Roche Professional Diagnostics




Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
Urine Analyzer
respons® UDS100
Gold Member
Nucleic Acid Extractor System
NEOS-96 XT
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: A new study links broad genomic sequencing before first-line therapy to longer survival, supporting its role in treatment decisions (Image Credit: Shutterstock)

Study Supports Broad Genomic Profiling Before First-Line Lung Cancer Treatment

Biomarker testing plays a critical role in advanced non-small cell lung cancer by identifying patients who may benefit from targeted therapies. However, testing only one or two genes can miss actionable... Read more

Immunology

view channel
Image: The findings underscore the importance of aligning allergy testing with clinical history and diagnostic guidelines to reduce inappropriate testing and its consequences (Image Credit: iStock)

Survey Finds Gap Between Food Allergy Testing Awareness and Clinical Practice

Food allergy evaluation can be challenging when laboratory results do not match clinical symptoms. Broad food allergy panels may detect sensitization without confirming an actual allergy, potentially leading... Read more

Industry

view channel
Image Credit: iStock

C2N Makes PrecivityAD2 Alzheimer’s Blood Test Available to Clinicians

Diagnosing Alzheimer’s disease can be challenging, particularly in patients with mild cognitive impairment or early dementia. Assessing brain amyloid pathology can guide clinical decisions, but diagnostic... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.